CN Stock MarketDetailed Quotes

300485 Beijing Science Sun Pharmaceutical

Watchlist
  • 7.32
  • -0.22-2.92%
Market Closed May 23 15:00 CST
3.53BMarket Cap-39782P/E (TTM)

Beijing Science Sun Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-17.46%109.54M
-35.12%476.57M
-34.28%393.82M
-29.04%272.04M
-30.92%132.7M
-30.10%734.55M
-25.97%599.23M
-26.55%383.34M
-17.60%192.1M
-3.97%1.05B
Operating revenue
-17.46%109.54M
-35.12%476.57M
-34.28%393.82M
-29.04%272.04M
-30.92%132.7M
-30.10%734.55M
-25.97%599.23M
-26.55%383.34M
-17.60%192.1M
-3.97%1.05B
Other operating revenue
----
-20.81%646.39K
----
--0
----
-28.80%816.2K
----
-35.82%540.97K
----
316.52%1.15M
Total operating cost
-20.30%103.93M
-27.15%517.65M
-33.39%373.63M
-27.99%259.86M
-23.50%130.4M
-24.81%710.54M
-21.57%560.94M
-22.59%360.86M
-16.54%170.45M
-0.40%945.02M
Operating cost
-2.40%37.16M
-17.87%140.94M
-18.92%112.7M
-13.95%76.43M
-12.08%38.08M
-5.77%171.61M
-11.83%139M
-11.90%88.81M
0.15%43.31M
2.70%182.12M
Operating tax surcharges
-18.86%712K
-16.24%7.4M
-41.61%4.68M
-12.56%4.01M
-73.90%877.46K
-24.74%8.83M
-20.98%8.02M
-21.74%4.58M
-10.14%3.36M
14.83%11.74M
Operating expense
-19.90%43.32M
-37.53%230.43M
-44.56%163.16M
-41.55%111.49M
-42.19%54.08M
-33.56%368.84M
-31.18%294.3M
-31.43%190.73M
-23.77%93.55M
-11.41%555.16M
Administration expense
29.89%13.82M
1.84%62.2M
-2.14%39.51M
-6.18%25.9M
-21.19%10.64M
-40.97%61.07M
-15.51%40.38M
-9.81%27.61M
-12.00%13.5M
35.71%103.45M
Financial expense
-220.60%-250.07K
-132.38%-1.05M
-130.21%-712.3K
-47.67%-340.87K
33.63%-78K
96.01%-451.3K
96.35%-309.42K
95.98%-230.83K
95.90%-117.52K
15.08%-11.3M
-Interest Income (Financial expense)
-192.01%-253.21K
-127.25%-1.1M
-125.98%-758.35K
-53.34%-383.35K
32.75%-86.71K
95.80%-485.66K
96.15%-335.58K
95.70%-249.99K
95.76%-128.93K
15.04%-11.56M
Research and development
-65.80%9.17M
-22.76%77.73M
-31.76%54.29M
-14.14%42.38M
59.10%26.8M
-3.09%100.63M
-1.14%79.56M
-12.62%49.36M
-23.59%16.85M
44.89%103.84M
Credit Impairment Loss
-109.88%-644.12K
550.35%1.65M
-138.22%-216.15K
-1,807.96%-980.69K
1,605.94%6.52M
-76.01%253.23K
-102.09%-90.73K
-101.99%-51.4K
-116.79%-432.91K
113.42%1.06M
Asset Impairment Loss
----
--0
----
----
----
--0
----
----
----
----
Other net revenue
-201,417.47%-230.64M
-29.40%162.81M
-19.98%195.87M
12.59%265.34M
-99.88%114.57K
-30.79%230.63M
284.04%244.77M
546.67%235.67M
404.21%99.31M
865.48%333.21M
Fair value change income
-1,970.60%-148.13M
-20.05%100.27M
-11.96%124.73M
17.04%167.09M
-110.16%-7.15M
-32.45%125.41M
465.12%141.68M
560.31%142.76M
922.56%70.44M
1,153.40%185.65M
Invest income
-12,408.75%-82.97M
-31.03%59.81M
-21.41%71.15M
23.45%99.15M
-96.73%674.1K
-34.70%86.71M
208.29%90.53M
584.98%80.32M
103.13%20.63M
407.13%132.78M
-Including: Investment income associates
-2,382.06%-90.93M
-13.35%46.92M
-9.84%61.35M
30.04%91.16M
-120.91%-3.66M
-40.97%54.15M
14,620.73%68.04M
1,429.66%70.1M
648.34%17.52M
6,169.34%91.72M
Asset deal income
----
-99.96%2.54K
----
----
----
1.23%6.65M
52.26%6.65M
--6.65M
--2.72M
3,868.98%6.57M
Other revenue
1,373.24%1.11M
-90.60%1.09M
-96.66%200.84K
-98.68%79.38K
-98.74%75.24K
62.30%11.61M
910.91%6.01M
1,060.15%6M
7,914.19%5.95M
231.59%7.15M
Operating profit
-9,424.25%-225.04M
-52.19%121.74M
-23.67%216.06M
7.50%277.51M
-98.00%2.41M
-42.00%254.64M
79.20%283.07M
179.92%258.16M
148.85%120.96M
144.00%439M
Add:Non operating Income
----
721.75%470.02K
-43.97%31.03K
15.06%28.38K
250.48%24.76K
-51.15%57.2K
-50.65%55.37K
-77.10%24.66K
995.97%7.07K
492.68%117.08K
Less:Non operating expense
1,065.87%1.1K
-44.43%43.17K
-76.59%18.18K
-60.95%994.35
-96.29%94.35
-15.61%77.68K
-34.81%77.68K
82.79%2.55K
131.47%2.55K
-85.75%92.05K
Total profit
-9,329.95%-225.04M
-52.02%122.16M
-23.66%216.07M
7.50%277.54M
-97.98%2.44M
-42.00%254.62M
79.19%283.05M
179.62%258.18M
148.87%120.96M
144.87%439.02M
Less:Income tax cost
-1,709.22%-32.69M
-50.44%25.76M
-30.66%22.79M
9.49%27.99M
-86.58%2.03M
18.40%51.97M
31.45%32.86M
150.18%25.57M
155.85%15.14M
56.71%43.89M
Net profit
SL-192.35M
-52.43%96.41M
-22.74%193.29M
7.28%249.54M
-99.62%406.47K
-48.71%202.65M
88.17%250.18M
183.28%232.61M
147.90%105.82M
161.19%395.13M
Net profit from continuing operation
-47,421.38%-192.35M
-52.43%96.41M
-22.74%193.29M
7.28%249.54M
-99.62%406.47K
-48.71%202.65M
88.17%250.18M
183.28%232.61M
147.90%105.82M
161.19%395.13M
Less:Minority Profit
-314.00%-1.73M
-212.23%-6.51M
-32.65%-3.24M
-34.93%-2.12M
42.73%-417.47K
70.78%-2.09M
48.66%-2.44M
51.26%-1.57M
-364.37%-728.98K
-97.10%-7.14M
Net profit of parent company owners
-23,235.01%-190.62M
-49.73%102.92M
-22.21%196.53M
7.47%251.66M
-99.23%823.94K
-49.11%204.73M
83.44%252.62M
174.43%234.18M
151.23%106.55M
159.69%402.27M
Earning per share
Basic earning per share
-23,376.47%-0.3957
-51.16%0.21
-21.15%0.41
6.12%0.52
-99.23%0.0017
-48.81%0.43
79.31%0.52
172.22%0.49
145.78%0.2212
162.50%0.84
Diluted earning per share
-23,376.47%-0.3957
-51.16%0.21
-21.15%0.41
6.12%0.52
-99.23%0.0017
-48.81%0.43
79.31%0.52
172.22%0.49
145.78%0.2212
162.50%0.84
Other composite income
113.28%61.7K
-79.89%591.67K
-70.21%1.08M
-22.01%1.31M
-238.16%-464.52K
494.73%2.94M
1,932.33%3.62M
617.81%1.68M
-159.24%-137.37K
60.17%-745.46K
Other composite income of parent company owners
113.28%61.7K
-79.89%591.67K
-70.21%1.08M
-22.01%1.31M
-238.16%-464.52K
494.73%2.94M
1,932.33%3.62M
617.81%1.68M
-159.24%-137.37K
60.17%-745.46K
Total composite income
-331,112.04%-192.28M
-52.82%97M
-23.42%194.36M
7.07%250.85M
-100.05%-58.05K
-47.87%205.59M
91.17%253.8M
186.45%234.29M
146.24%105.68M
163.96%394.39M
Total composite income of parent company owners
-53,118.56%-190.56M
-50.16%103.51M
-22.88%197.6M
7.26%252.97M
-99.66%359.41K
-48.28%207.68M
86.33%256.24M
177.45%235.86M
149.54%106.41M
162.38%401.53M
Total composite income of minority owners
-314.00%-1.73M
-212.23%-6.51M
-32.65%-3.24M
-34.93%-2.12M
42.73%-417.47K
70.78%-2.09M
48.66%-2.44M
51.26%-1.57M
-364.37%-728.98K
-97.10%-7.14M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -17.46%109.54M-35.12%476.57M-34.28%393.82M-29.04%272.04M-30.92%132.7M-30.10%734.55M-25.97%599.23M-26.55%383.34M-17.60%192.1M-3.97%1.05B
Operating revenue -17.46%109.54M-35.12%476.57M-34.28%393.82M-29.04%272.04M-30.92%132.7M-30.10%734.55M-25.97%599.23M-26.55%383.34M-17.60%192.1M-3.97%1.05B
Other operating revenue -----20.81%646.39K------0-----28.80%816.2K-----35.82%540.97K----316.52%1.15M
Total operating cost -20.30%103.93M-27.15%517.65M-33.39%373.63M-27.99%259.86M-23.50%130.4M-24.81%710.54M-21.57%560.94M-22.59%360.86M-16.54%170.45M-0.40%945.02M
Operating cost -2.40%37.16M-17.87%140.94M-18.92%112.7M-13.95%76.43M-12.08%38.08M-5.77%171.61M-11.83%139M-11.90%88.81M0.15%43.31M2.70%182.12M
Operating tax surcharges -18.86%712K-16.24%7.4M-41.61%4.68M-12.56%4.01M-73.90%877.46K-24.74%8.83M-20.98%8.02M-21.74%4.58M-10.14%3.36M14.83%11.74M
Operating expense -19.90%43.32M-37.53%230.43M-44.56%163.16M-41.55%111.49M-42.19%54.08M-33.56%368.84M-31.18%294.3M-31.43%190.73M-23.77%93.55M-11.41%555.16M
Administration expense 29.89%13.82M1.84%62.2M-2.14%39.51M-6.18%25.9M-21.19%10.64M-40.97%61.07M-15.51%40.38M-9.81%27.61M-12.00%13.5M35.71%103.45M
Financial expense -220.60%-250.07K-132.38%-1.05M-130.21%-712.3K-47.67%-340.87K33.63%-78K96.01%-451.3K96.35%-309.42K95.98%-230.83K95.90%-117.52K15.08%-11.3M
-Interest Income (Financial expense) -192.01%-253.21K-127.25%-1.1M-125.98%-758.35K-53.34%-383.35K32.75%-86.71K95.80%-485.66K96.15%-335.58K95.70%-249.99K95.76%-128.93K15.04%-11.56M
Research and development -65.80%9.17M-22.76%77.73M-31.76%54.29M-14.14%42.38M59.10%26.8M-3.09%100.63M-1.14%79.56M-12.62%49.36M-23.59%16.85M44.89%103.84M
Credit Impairment Loss -109.88%-644.12K550.35%1.65M-138.22%-216.15K-1,807.96%-980.69K1,605.94%6.52M-76.01%253.23K-102.09%-90.73K-101.99%-51.4K-116.79%-432.91K113.42%1.06M
Asset Impairment Loss ------0--------------0----------------
Other net revenue -201,417.47%-230.64M-29.40%162.81M-19.98%195.87M12.59%265.34M-99.88%114.57K-30.79%230.63M284.04%244.77M546.67%235.67M404.21%99.31M865.48%333.21M
Fair value change income -1,970.60%-148.13M-20.05%100.27M-11.96%124.73M17.04%167.09M-110.16%-7.15M-32.45%125.41M465.12%141.68M560.31%142.76M922.56%70.44M1,153.40%185.65M
Invest income -12,408.75%-82.97M-31.03%59.81M-21.41%71.15M23.45%99.15M-96.73%674.1K-34.70%86.71M208.29%90.53M584.98%80.32M103.13%20.63M407.13%132.78M
-Including: Investment income associates -2,382.06%-90.93M-13.35%46.92M-9.84%61.35M30.04%91.16M-120.91%-3.66M-40.97%54.15M14,620.73%68.04M1,429.66%70.1M648.34%17.52M6,169.34%91.72M
Asset deal income -----99.96%2.54K------------1.23%6.65M52.26%6.65M--6.65M--2.72M3,868.98%6.57M
Other revenue 1,373.24%1.11M-90.60%1.09M-96.66%200.84K-98.68%79.38K-98.74%75.24K62.30%11.61M910.91%6.01M1,060.15%6M7,914.19%5.95M231.59%7.15M
Operating profit -9,424.25%-225.04M-52.19%121.74M-23.67%216.06M7.50%277.51M-98.00%2.41M-42.00%254.64M79.20%283.07M179.92%258.16M148.85%120.96M144.00%439M
Add:Non operating Income ----721.75%470.02K-43.97%31.03K15.06%28.38K250.48%24.76K-51.15%57.2K-50.65%55.37K-77.10%24.66K995.97%7.07K492.68%117.08K
Less:Non operating expense 1,065.87%1.1K-44.43%43.17K-76.59%18.18K-60.95%994.35-96.29%94.35-15.61%77.68K-34.81%77.68K82.79%2.55K131.47%2.55K-85.75%92.05K
Total profit -9,329.95%-225.04M-52.02%122.16M-23.66%216.07M7.50%277.54M-97.98%2.44M-42.00%254.62M79.19%283.05M179.62%258.18M148.87%120.96M144.87%439.02M
Less:Income tax cost -1,709.22%-32.69M-50.44%25.76M-30.66%22.79M9.49%27.99M-86.58%2.03M18.40%51.97M31.45%32.86M150.18%25.57M155.85%15.14M56.71%43.89M
Net profit SL-192.35M-52.43%96.41M-22.74%193.29M7.28%249.54M-99.62%406.47K-48.71%202.65M88.17%250.18M183.28%232.61M147.90%105.82M161.19%395.13M
Net profit from continuing operation -47,421.38%-192.35M-52.43%96.41M-22.74%193.29M7.28%249.54M-99.62%406.47K-48.71%202.65M88.17%250.18M183.28%232.61M147.90%105.82M161.19%395.13M
Less:Minority Profit -314.00%-1.73M-212.23%-6.51M-32.65%-3.24M-34.93%-2.12M42.73%-417.47K70.78%-2.09M48.66%-2.44M51.26%-1.57M-364.37%-728.98K-97.10%-7.14M
Net profit of parent company owners -23,235.01%-190.62M-49.73%102.92M-22.21%196.53M7.47%251.66M-99.23%823.94K-49.11%204.73M83.44%252.62M174.43%234.18M151.23%106.55M159.69%402.27M
Earning per share
Basic earning per share -23,376.47%-0.3957-51.16%0.21-21.15%0.416.12%0.52-99.23%0.0017-48.81%0.4379.31%0.52172.22%0.49145.78%0.2212162.50%0.84
Diluted earning per share -23,376.47%-0.3957-51.16%0.21-21.15%0.416.12%0.52-99.23%0.0017-48.81%0.4379.31%0.52172.22%0.49145.78%0.2212162.50%0.84
Other composite income 113.28%61.7K-79.89%591.67K-70.21%1.08M-22.01%1.31M-238.16%-464.52K494.73%2.94M1,932.33%3.62M617.81%1.68M-159.24%-137.37K60.17%-745.46K
Other composite income of parent company owners 113.28%61.7K-79.89%591.67K-70.21%1.08M-22.01%1.31M-238.16%-464.52K494.73%2.94M1,932.33%3.62M617.81%1.68M-159.24%-137.37K60.17%-745.46K
Total composite income -331,112.04%-192.28M-52.82%97M-23.42%194.36M7.07%250.85M-100.05%-58.05K-47.87%205.59M91.17%253.8M186.45%234.29M146.24%105.68M163.96%394.39M
Total composite income of parent company owners -53,118.56%-190.56M-50.16%103.51M-22.88%197.6M7.26%252.97M-99.66%359.41K-48.28%207.68M86.33%256.24M177.45%235.86M149.54%106.41M162.38%401.53M
Total composite income of minority owners -314.00%-1.73M-212.23%-6.51M-32.65%-3.24M-34.93%-2.12M42.73%-417.47K70.78%-2.09M48.66%-2.44M51.26%-1.57M-364.37%-728.98K-97.10%-7.14M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg